Florbetapir F 18
Florbetapir F 18 is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Amyvid. Available dosage form: injection, solution.
Drug Details
- Generic Name
- Florbetapir F 18
- Brand Names
- Amyvid
- Application Number
- NDA202008
- Sponsor
- Eli Lilly and Company
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- FLORBETAPIR F-18
Indications and Usage
1 INDICATIONS AND USAGE AMYVID is indicated for positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information of the therapeutic products AMYVID is a radioactive diagnostic drug indicated for positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for: Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information of the therapeutic products ( 1 )